FDA’s OTP Super Office on Track to Fill 500 Positions

The director of the FDA’s Center for Biologics Evaluation and Research (CBER) Peter Marks said he’s reasonably comfortable with the progress being made to fill up to 500 vacancies at the agency’s Office of Therapeutic Products (OTP).